CNE100005Q22
CNE100005Q22
INVENTISBIO CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 37.289.661 | 168.790.398 | 77.9% |
| Cost of Revenue | 5.018.017 | 3.923.936 | 27.9% |
| Gross Profit | 32.271.644 | 164.866.461 | 80.4% |
| 362.337.261 | 428.371.652 | 15.4% | |
| Operating Income | -330.065.616 | -263.505.191 | 25.3% |
| Pretax Income | -316.626.275 | -240.203.845 | 31.8% |
| Net Income Common Stockholders | -316.865.801 | -240.203.845 | 31.9% |
| -- | -- | -- | |
| -- | -- | -- |